Is there a Failure to Optimize theRapy in anGina pEcToris (FORGET) study?

QJM: An International Journal of Medicine

Volumn 103, Issue 5, 2010, Pages 305-310

  Elder, D H J ^a   Pauriah, M ^a   Lang, C C ^a   Shand, J ^b   Menown, I B A ^b   Sin B D W C K , ^c   Gupta, S ^c   Duckett, S G ^d   Foster, W ^e   Zachariah, D ^f   Kalra, P R ^f  

^a NHS TAYSIDE   (United Kingdom)

^b Department of Cardiology   (United Kingdom)

^c BARTS HEALTH NHS TRUST   (United Kingdom)

^d SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^e Christchurch Hospital Dorset   (United Kingdom)

^f PORTSMOUTH HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IVABRADINE; NICORANDIL; NITRATE;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; DRUG DOSE COMPARISON; DRUG TARGETING; FEMALE; HEALTH CARE PLANNING; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SECONDARY PREVENTION; STABLE ANGINA PECTORIS; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; UNITED KINGDOM;

EID: 77953063545     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcq011     Document Type: Article

References (9)

1. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and fast revascularisation during instability in coronary artery disease investigators. Lancet 1999; 354:708-15.
2. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary dis- ease. N Engl J Med 2007; 356:1503-16.
3. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, et al. Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006; 27:1341-81.
4. Fraker TD Jr, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. Circulation 2007; 116:2762-72.
5. Menown IBA. Resting heart rate as a cardiovascular risk factor? MIMS Cardiovascular 2008; 3:18-21.
6. Abraham WT. Switching between beta blockers in heart failure. Rationale and practical considerations. Congest Heart Fail 2003; 9:271-8.
7. PRODIGY guidance on hypertension. [http://www.prodigy.nhs.uk/hypertension] (Accessed 24 May 2009).
8. Mancia G, DeBacker G. 2007 Guidelines for the management of arterial hypertension, European Society of Cardiology. Eur Heart J 2007; 28:1462-536.
9. Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R, et al. BEAUTIFUL investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 2008; 372:817-21.